10 20 30 40 50 60 70 80 1RHJ - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER HYDROLASE 14-NOV-03 1RHJ
TITLE CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A TITLE 2 PRYAZINONE INHIBITOR
COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASPASE-3; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: P17 SUBUNIT; COMPND 5 SYNONYM: CYSTEINE PROTEASE CPP32, YAMA PROTEIN, CPP-32, COMPND 6 APOPAIN, CASP-3, SREBP CLEAVAGE ACTIVITY 1, SCA-1; COMPND 7 EC: 3.4.22.-; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: CASPASE-3; COMPND 11 CHAIN: B, D; COMPND 12 FRAGMENT: P12 SUBUNIT; COMPND 13 SYNONYM: CYSTEINE PROTEASE CPP32, YAMA PROTEIN, CPP-32, COMPND 14 APOPAIN, CASP-3, SREBP CLEAVAGE ACTIVITY 1, SCA-1; COMPND 15 EC: 3.4.22.-; COMPND 16 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CASP3, CPP32; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET20B+; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: CASP3, CPP32; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID
KEYWDS CYSTEINE PROTEASE, CASPASE-3, APOPAIN, CPP32, YAMA, COMPLEX KEYWDS 2 (PROTEASE/INHIBITOR), HYDROLASE
EXPDTA X-RAY DIFFRACTION
AUTHOR J.W.BECKER,J.ROTONDA,S.M.SOISSON
REVDAT 2 24-FEB-09 1RHJ 1 VERSN REVDAT 1 11-MAY-04 1RHJ 0
JRNL AUTH J.W.BECKER,J.ROTONDA,S.M.SOISSON,R.ASPIOTIS, JRNL AUTH 2 C.BAYLY,S.FRANCOEUR,M.GALLANT,M.GARCIA-CALVO, JRNL AUTH 3 A.GIROUX,E.GRIMM,Y.HAN,D.MCKAY,D.W.NICHOLSON, JRNL AUTH 4 E.PETERSON,J.RENAUD,S.ROY,N.THORNBERRY,R.ZAMBONI JRNL TITL REDUCING THE PEPTIDYL FEATURES OF CASPASE-3 JRNL TITL 2 INHIBITORS: A STRUCTURAL ANALYSIS. JRNL REF J.MED.CHEM. V. 47 2466 2004 JRNL REFN ISSN 0022-2623 JRNL PMID 15115390 JRNL DOI 10.1021/JM0305523
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2002 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.90 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 175071.300 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.1 REMARK 3 NUMBER OF REFLECTIONS : 29784 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.252 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2987 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 29784 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 87.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4086 REMARK 3 BIN R VALUE (WORKING SET) : 0.2250 REMARK 3 BIN FREE R VALUE : 0.2850 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 469 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.013 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3740 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 82 REMARK 3 SOLVENT ATOMS : 233 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 10.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.58000 REMARK 3 B22 (A**2) : 3.84000 REMARK 3 B33 (A**2) : -4.42000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -3.76000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM SIGMAA (A) : 0.18 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.27 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.30 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.00 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.320 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.070 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.220 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.200 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 40.66 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.P REMARK 3 PARAMETER FILE 2 : WATER_REP.PAR REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : PYR.PAR REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : PYR.TOP REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED
REMARK 4 REMARK 4 1RHJ COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-NOV-03. REMARK 100 THE RCSB ID CODE IS RCSB020749.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-SEP-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30288 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 19.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.6 REMARK 200 DATA REDUNDANCY : 3.360 REMARK 200 R MERGE (I) : 0.05600 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 76.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.41 REMARK 200 R MERGE FOR SHELL (I) : 0.16400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNX REMARK 200 STARTING MODEL: PROTEIN PART OF 1PAU.PDB REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.66 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.65 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16% PEG-6000, 100 MM CITRATE, 20 MM REMARK 280 L-CYSTEINE, 5 MM GLYCEROL, 3 MM NAN(3), PH 4.8, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.38200 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE ASYMMETRIC UNIT CONTAINS ONE BIOLOGICAL ASSEMBLY.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 15170 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17050 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -71.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 145 REMARK 465 GLY A 146 REMARK 465 ILE A 147 REMARK 465 SER A 148 REMARK 465 LEU A 149 REMARK 465 THR A 296 REMARK 465 ASP A 297 REMARK 465 SER B 310 REMARK 465 GLY B 311 REMARK 465 VAL B 312 REMARK 465 ASP B 313 REMARK 465 ASP B 314 REMARK 465 ASP B 315 REMARK 465 MET B 316 REMARK 465 ALA B 317 REMARK 465 CYS B 318 REMARK 465 HIS B 319 REMARK 465 HIS B 402 REMARK 465 LEU B 403 REMARK 465 GLU B 404 REMARK 465 HIS B 405 REMARK 465 HIS B 406 REMARK 465 HIS B 407 REMARK 465 HIS B 408 REMARK 465 HIS B 409 REMARK 465 HIS B 410 REMARK 465 SER C 645 REMARK 465 GLY C 646 REMARK 465 ILE C 647 REMARK 465 SER C 648 REMARK 465 LEU C 649 REMARK 465 THR C 796 REMARK 465 ASP C 797 REMARK 465 SER D 810 REMARK 465 GLY D 811 REMARK 465 VAL D 812 REMARK 465 ASP D 813 REMARK 465 ASP D 814 REMARK 465 ASP D 815 REMARK 465 MET D 816 REMARK 465 ALA D 817 REMARK 465 CYS D 818 REMARK 465 HIS D 819 REMARK 465 HIS D 902 REMARK 465 LEU D 903 REMARK 465 GLU D 904 REMARK 465 HIS D 905 REMARK 465 HIS D 906 REMARK 465 HIS D 907 REMARK 465 HIS D 908 REMARK 465 HIS D 909 REMARK 465 HIS D 910
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 175A -1.66 -58.09 REMARK 500 LYS A 197 30.85 78.59 REMARK 500 ASP A 205 73.49 35.98 REMARK 500 SER A 236 -170.27 -175.07 REMARK 500 CYS A 270 79.46 -119.97 REMARK 500 LYS B 363 -58.21 -130.85 REMARK 500 PHE B 400 30.87 -84.23 REMARK 500 LYS C 697 32.34 72.22 REMARK 500 ASP C 705 75.67 42.63 REMARK 500 SER C 736 -170.78 -178.38 REMARK 500 ASP D 826 32.98 74.27 REMARK 500 LYS D 863 -46.64 -145.08 REMARK 500 PHE D 900 30.07 -84.79 REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PZN C 502 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PZN A 501
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1PAU RELATED DB: PDB REMARK 900 CASPASE-3 COMPLEX WITH ACETYL-ASP-GLU-VAL-ASP-ALDEHYDE REMARK 900 RELATED ID: 1RHK RELATED DB: PDB REMARK 900 RELATED ID: 1RHM RELATED DB: PDB REMARK 900 RELATED ID: 1RHQ RELATED DB: PDB REMARK 900 RELATED ID: 1RHR RELATED DB: PDB REMARK 900 RELATED ID: 1RHU RELATED DB: PDB
REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE HIS TAGS ON CHAINS B AND D WERE NOT REMARK 999 CLEAVED FOR THIS ENTRY.
DBREF 1RHJ A 145 297 UNP P42574 CASP3_HUMAN 29 175 DBREF 1RHJ B 310 402 UNP P42574 CASP3_HUMAN 176 277 DBREF 1RHJ C 645 797 UNP P42574 CASP3_HUMAN 29 175 DBREF 1RHJ D 810 902 UNP P42574 CASP3_HUMAN 176 277
SEQADV 1RHJ GLU B 324 UNP P42574 ASP 190 ISOFORM BETA SEQADV 1RHJ LEU B 403 UNP P42574 EXPRESSION TAG SEQADV 1RHJ GLU B 404 UNP P42574 EXPRESSION TAG SEQADV 1RHJ HIS B 405 UNP P42574 EXPRESSION TAG SEQADV 1RHJ HIS B 406 UNP P42574 EXPRESSION TAG SEQADV 1RHJ HIS B 407 UNP P42574 EXPRESSION TAG SEQADV 1RHJ HIS B 408 UNP P42574 EXPRESSION TAG SEQADV 1RHJ HIS B 409 UNP P42574 EXPRESSION TAG SEQADV 1RHJ HIS B 410 UNP P42574 EXPRESSION TAG SEQADV 1RHJ GLU D 824 UNP P42574 ASP 190 ISOFORM BETA SEQADV 1RHJ LEU D 903 UNP P42574 EXPRESSION TAG SEQADV 1RHJ GLU D 904 UNP P42574 EXPRESSION TAG SEQADV 1RHJ HIS D 905 UNP P42574 EXPRESSION TAG SEQADV 1RHJ HIS D 906 UNP P42574 EXPRESSION TAG SEQADV 1RHJ HIS D 907 UNP P42574 EXPRESSION TAG SEQADV 1RHJ HIS D 908 UNP P42574 EXPRESSION TAG SEQADV 1RHJ HIS D 909 UNP P42574 EXPRESSION TAG SEQADV 1RHJ HIS D 910 UNP P42574 EXPRESSION TAG
SEQRES 1 A 147 SER GLY ILE SER LEU ASP ASN SER TYR LYS MET ASP TYR SEQRES 2 A 147 PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN LYS ASN SEQRES 3 A 147 PHE HIS LYS SER THR GLY MET THR SER ARG SER GLY THR SEQRES 4 A 147 ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE ARG ASN SEQRES 5 A 147 LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU THR ARG SEQRES 6 A 147 GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER LYS GLU SEQRES 7 A 147 ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL LEU LEU SEQRES 8 A 147 SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR ASN GLY SEQRES 9 A 147 PRO VAL ASP LEU LYS LYS ILE THR ASN PHE PHE ARG GLY SEQRES 10 A 147 ASP ARG CYS ARG SER LEU THR GLY LYS PRO LYS LEU PHE SEQRES 11 A 147 ILE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP CYS GLY SEQRES 12 A 147 ILE GLU THR ASP SEQRES 1 B 110 SER GLY VAL ASP ASP ASP MET ALA CYS HIS LYS ILE PRO SEQRES 2 B 110 VAL GLU ALA ASP PHE LEU TYR ALA TYR SER THR ALA PRO SEQRES 3 B 110 GLY TYR TYR SER TRP ARG ASN SER LYS ASP GLY SER TRP SEQRES 4 B 110 PHE ILE GLN SER LEU CYS ALA MET LEU LYS GLN TYR ALA SEQRES 5 B 110 ASP LYS LEU GLU PHE MET HIS ILE LEU THR ARG VAL ASN SEQRES 6 B 110 ARG LYS VAL ALA THR GLU PHE GLU SER PHE SER PHE ASP SEQRES 7 B 110 ALA THR PHE HIS ALA LYS LYS GLN ILE PRO CYS ILE VAL SEQRES 8 B 110 SER MET LEU THR LYS GLU LEU TYR PHE TYR HIS LEU GLU SEQRES 9 B 110 HIS HIS HIS HIS HIS HIS SEQRES 1 C 147 SER GLY ILE SER LEU ASP ASN SER TYR LYS MET ASP TYR SEQRES 2 C 147 PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN LYS ASN SEQRES 3 C 147 PHE HIS LYS SER THR GLY MET THR SER ARG SER GLY THR SEQRES 4 C 147 ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE ARG ASN SEQRES 5 C 147 LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU THR ARG SEQRES 6 C 147 GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER LYS GLU SEQRES 7 C 147 ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL LEU LEU SEQRES 8 C 147 SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR ASN GLY SEQRES 9 C 147 PRO VAL ASP LEU LYS LYS ILE THR ASN PHE PHE ARG GLY SEQRES 10 C 147 ASP ARG CYS ARG SER LEU THR GLY LYS PRO LYS LEU PHE SEQRES 11 C 147 ILE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP CYS GLY SEQRES 12 C 147 ILE GLU THR ASP SEQRES 1 D 110 SER GLY VAL ASP ASP ASP MET ALA CYS HIS LYS ILE PRO SEQRES 2 D 110 VAL GLU ALA ASP PHE LEU TYR ALA TYR SER THR ALA PRO SEQRES 3 D 110 GLY TYR TYR SER TRP ARG ASN SER LYS ASP GLY SER TRP SEQRES 4 D 110 PHE ILE GLN SER LEU CYS ALA MET LEU LYS GLN TYR ALA SEQRES 5 D 110 ASP LYS LEU GLU PHE MET HIS ILE LEU THR ARG VAL ASN SEQRES 6 D 110 ARG LYS VAL ALA THR GLU PHE GLU SER PHE SER PHE ASP SEQRES 7 D 110 ALA THR PHE HIS ALA LYS LYS GLN ILE PRO CYS ILE VAL SEQRES 8 D 110 SER MET LEU THR LYS GLU LEU TYR PHE TYR HIS LEU GLU SEQRES 9 D 110 HIS HIS HIS HIS HIS HIS
HET PZN C 502 41 HET PZN A 501 41
HETNAM PZN 3-(2-{5-TERT-BUTYL-3-[(4-METHYL-FURAZAN-3-YLMETHYL)- HETNAM 2 PZN AMINO]-2-OXO-2H-PYRAZIN-1-YL}-BUTYRYLAMINO)-5-(HEXYL- HETNAM 3 PZN METHYL-AMINO)-4-OXO-PENTANOIC ACID ANION
FORMUL 5 PZN 2(C28 H44 N7 O6 1-) FORMUL 7 HOH *233(H2 O)
HELIX 1 1 HIS A 174 GLY A 175C 5 5 HELIX 2 2 GLY A 181 LEU A 196 1 16 HELIX 3 3 THR A 207 LYS A 220 1 14 HELIX 4 4 LEU A 258 PHE A 264 1 7 HELIX 5 5 CYS A 270 THR A 274 5 5 HELIX 6 6 TRP B 348 ALA B 361 1 14 HELIX 7 7 GLU B 365 PHE B 380 1 17 HELIX 8 8 ASP B 381E HIS B 381I 5 5 HELIX 9 9 HIS C 674 GLY C 675C 5 5 HELIX 10 10 GLY C 681 LEU C 696 1 16 HELIX 11 11 THR C 707 GLU C 721 1 15 HELIX 12 12 LEU C 758 PHE C 764 1 7 HELIX 13 13 CYS C 770 THR C 774 5 5 HELIX 14 14 TRP D 848 ALA D 861 1 14 HELIX 15 15 GLU D 865 PHE D 880 1 17 HELIX 16 16 ASP D 881E HIS D 881I 5 5
SHEET 1 A12 GLU A 199 ASN A 204 0 SHEET 2 A12 GLU A 162 ASN A 169 1 N ILE A 167 O ARG A 201 SHEET 3 A12 ARG A 227 LEU A 235 1 O VAL A 233 N ILE A 166 SHEET 4 A12 LYS A 278 GLN A 283 1 O LEU A 279 N PHE A 230 SHEET 5 A12 PHE B 327 TYR B 331 1 O LEU B 328 N PHE A 280 SHEET 6 A12 CYS B 388 SER B 392 -1 O VAL B 390 N TYR B 329 SHEET 7 A12 CYS D 888 MET D 893 -1 O SER D 892 N ILE B 389 SHEET 8 A12 PHE D 827 TYR D 831 -1 N TYR D 829 O VAL D 890 SHEET 9 A12 LYS C 778 GLN C 783 1 N PHE C 780 O LEU D 828 SHEET 10 A12 ARG C 727 LEU C 735 1 N PHE C 730 O LEU C 779 SHEET 11 A12 GLU C 662 ASN C 669 1 N ILE C 666 O VAL C 733 SHEET 12 A12 GLU C 699 ASN C 704 1 O LYS C 703 N ASN C 669 SHEET 1 B 3 GLY A 238 GLU A 239 0 SHEET 2 B 3 ILE A 242 GLY A 245 -1 O ILE A 242 N GLU A 239 SHEET 3 B 3 GLY A 254 ASP A 257 -1 O GLY A 254 N GLY A 245 SHEET 1 C 2 ARG B 341 ASN B 342 0 SHEET 2 C 2 GLY B 346 SER B 347 -1 O GLY B 346 N ASN B 342 SHEET 1 D 3 GLY C 738 GLU C 739 0 SHEET 2 D 3 ILE C 742 GLY C 745 -1 O ILE C 742 N GLU C 739 SHEET 3 D 3 GLY C 754 ASP C 757 -1 O GLY C 754 N GLY C 745 SHEET 1 E 2 ARG D 841 ASN D 842 0 SHEET 2 E 2 GLY D 846 SER D 847 -1 O GLY D 846 N ASN D 842
LINK SG CYS A 285 C9 PZN A 501 1555 1555 1.85 LINK SG CYS C 785 C9 PZN C 502 1555 1555 1.85
SITE 1 AC1 13 HOH C 190 ARG C 679 SER C 736 HIS C 737 SITE 2 AC1 13 GLY C 738 GLN C 783 CYS C 785 TYR D 838 SITE 3 AC1 13 SER D 839 TRP D 840 ARG D 841 SER D 881A SITE 4 AC1 13 PHE D 881B SITE 1 AC2 15 ARG A 179 HIS A 237 GLY A 238 GLN A 283 SITE 2 AC2 15 ALA A 284 CYS A 285 HOH A 519 HOH A 524 SITE 3 AC2 15 TYR B 338 SER B 339 TRP B 340 ARG B 341 SITE 4 AC2 15 SER B 381A PHE B 381B PHE B 381H
CRYST1 50.187 68.764 93.008 90.00 101.46 90.00 P 1 21 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.019925 0.000000 0.004039 0.00000
SCALE2 0.000000 0.014542 0.000000 0.00000
SCALE3 0.000000 0.000000 0.010970 0.00000